Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
AVIR holding history
Atea Pharmaceuticals, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVIR overviewAll 13F holders of AVIRFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −8,235−100.0% | Sold out | Holders |
| Q2 2024 | 8,235 | $27.3K | <0.1% | −18,154−68.8% | Reduced | Holders |
| Q1 2024 | 26,389 | $106.6K | <0.1% | −26,649−50.2% | Reduced | Holders |
| Q4 2023 | 53,038 | $161.8K | <0.1% | +13,422+33.9% | Added | Holders |
| Q3 2023 | 39,616 | $118.8K | <0.1% | +6,829+20.8% | Added | Holders |
| Q2 2023 | 32,787 | $122.6K | <0.1% | +32,787 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −60,067−100.0% | Sold out | Holders |
| Q2 2022 | 60,067 | $426.0K | <0.1% | +20,892+53.3% | Added | Holders |
| Q1 2022 | 39,175 | $283.0K | <0.1% | +39,175 | New | Holders |